Close

TESARO (TSRO), ENGOT Announce Niraparib Phase 3 ENGOT-OV16/NOVA Met Primary Endpoint

October 10, 2016 6:58 AM EDT Send to a Friend
TESARO, Inc. (Nasdaq: TSRO) and ENGOT, the European Network for Gynaecological Oncological Trial groups, announced the presentation of the niraparib ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login